Home ›
News ›
Pfizer Profits Dip As It Ramps R&D Spending For New Drugs
NEWS● Neutral
5 sources confirmed
Pfizer Profits Dip As It Ramps R&D Spending For New Drugs
While the company has continued to pay dividends, it has refrained from share repurchases and said Tuesday that it doesn't plan any in 2026. The post Pfizer Profits Dip As It Ramps R&D Spending For New Drugs appeared first on Channels Television.
BF
The Briefing Africa
May 5, 2026 · 14:00 · 5 min read
Share:
AI Summary
While the company has continued to pay dividends, it has refrained from share repurchases and said Tuesday that it doesn't plan any in 2026. The post Pfizer Profits Dip As It Ramps R&D Spending For New Drugs appeared first on Channels Television.
AI-generated summary ·
Highlight any paragraph below to share it as a branded quote card
Full analysis is being generated — check back shortly.